BioCryst Pharma Stock Price (NASDAQ:BCRX)

Add to My Stocks
$8.79 $0.3 (3.53%) BCRX stock closing price Mar 24, 2017 (Closing)
YOUR DAILY UPDATE ON
BCRX
BioCryst Pharma
24 MAR 2017
amigobulls logo
BCRX hand_up
BCRX vs S&P 500
Closing Price: Mar 24, 2017
BCRX
$8.79 ( 3.47%)
S&P 500
2344 ( -0.08%)
BCRX
52 Week Price Range
1 Year Return: 204.3%
Q4 Growth*
Excellent
Profitable ?
No
net image
2016 Q4 Net Loss
-209.3%
home image
Rating
BCRX POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

BioCryst Pharma Snapshot Video

11 5 2

BCRX Stock Details

Prev Close* : $8.49
Market Cap:
$703.5M
Day Low: $8.52
52 Week Low: $2.48
Open: $8.61
Volume: 967338
Day High: $8.87
52 Week High: $9.25
Dividend:
N/A

Latest Stock Market News

Latest Articles

BioCryst Pharma News - From Partners

Company News for February 09, 2016   by Zacks on Feb 09, 2016

BCRX Stockcharts

View BCRX PE ratio, PS ratio stocks charts and compare with peers.
BCRX Chart
Note: Compare BioCryst Pharma stock price history with the index and industry peers.

BioCryst Pharma Valuation

PS ratio (
price to sales ratio
)
24.59
PB ratio (
price to book ratio
)
34.3

BioCryst Pharma Financial Ratios

Asset Turnover
0.36
Receivables Turnover
3.75
Debt to Equity
13.87

BCRX Industry Peers

Company Price Change (%)
Durata Therapeutics (DRTX)24.160.41 (1.73%)
La Jolla Pharma (LJPC)34.920.1 (0.29%)
Gilead Sciences (GILD)67.510.02 (0.03%)
Sarepta Therapeutics (SRPT)29.930.25 (0.84%)
Aviragen Therapeutics (AVIR)0.650.01 (1.56%)
Achillion Pharma (ACHN)3.760.03 (0.79%)
Nanoviricides (NNVC)1.120.03 (2.61%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)7.40.32 (4.52%)
Tesaro Inc (TSRO)1606.38 (4.15%)
Ignyta (RXDX)9.250.35 (3.93%)
Flexion Therapeutics (FLXN)27.271.02 (3.89%)
BioCryst Pharma (BCRX)8.7850.3 (3.53%)
Xencor (XNCR)24.530.82 (3.46%)
Infinity Pharma (INFI)3.30.1 (3.13%)
Top gainers from Medical-Drugs industry
* As of Mar 25, 2017
CompanyPriceChange (%)
MediWound (MDWD)6.40.27 (4.04%)
Nature's Sunshine Products (NATR)9.150.35 (3.68%)
Esperion Therapeutics (ESPR)38.941.46 (3.61%)
Merus Labs International (MSLI)0.860.03 (3.37%)
Concert Pharma (CNCE)17.3950.48 (2.68%)
GlycoMimetics (GLYC)5.560.12 (2.11%)
Aralez Pharma (ARLZ)2.190.04 (1.79%)
Top losers from Medical-Drugs industry
* As of Mar 25, 2017

BioCryst Pharmaceuticals, Inc. Stock News - Partner Headlines

BioCryst Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues48.25M13.6M17.33M26.29M19.64M
Net Income-43.01M-45.18M-30.1M-39.08M-56.94M
Total Operating Expense86.32M59.37M48.04M60.17M69.22M
view BioCryst Pharmaceuticals, Inc. income statement
balance sheet20152014201320122011
Total Assets124.55M136.87M48.86M57.43M82.2M
Total Liabilities76.83M61.23M49.99M57.89M67.4M
Shareholders Equity47.72M75.63M-1.12M-0.45M14.8M
view BioCryst Pharmaceuticals, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities19.01M1.3M3.8M-4.29M14.68M
Net Cash From (Used By) Operating Activities-13.11M-38.55M-26.53M-37.39M-32.25M
Increase (Decrease) In Prop Plant And Equipment-5.12M-0.1M0.02M-0.11M-0.05M
view BioCryst Pharmaceuticals, Inc. cashflow statement

BioCryst Pharma Stock Message Board

BioCryst Pharma stock lost 3.47 %, and the last close price as of 24 Mar, 2017 is 8.79 for BCRX stock. BioCryst Pharma market capitalization is 679.88M and it represents the total market value of BCRX stock. A value investor must look at the fundamentals of a stock, and perform BioCryst Pharma valuation, even though in the short-term sentiment and current breaking news might affect BioCryst Pharma stock price.

For recognizing and analyzing the real performance of BioCryst Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 967338 shares were traded with a closing stock price of 8.79 as of 24 Mar, 2017, as can be seen from BioCryst Pharma stock quote. One can view BioCryst Pharma stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. BioCryst Pharma does not pay dividends. BioCryst Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.